Weekly Digital Marketing / SEO Briefing — Week ending 22 Aug 2026

Baseline week: There is no prior-week comparison, and the rolling history contains only this week. We can identify demand and answer gaps, but not yet confirm recurrence or growth.

1. Content opportunities this week

1. “Can ivermectin be used for scabies, and what dose schedule is recommended for adults?”
   Seven responses address it, but answers vary on contraindications, infection-risk context, and dosing details. A clinician-reviewed, citation-led guide could provide one clear explanation of treatment role, adult regimen, repeat timing, alternatives, and safety boundaries.

2. “What are the contraindications for ivermectin, and when should it definitely be avoided?”
   This is a high-value safety question with seven responses and disagreement over whether pregnancy/lactation belongs in the definitive guidance. The overall dataset also contains 29 contraindication and 18 pregnancy/lactation tags, supporting a dedicated, clearly structured reference page.

3. “What serious adverse reactions should I watch for with ivermectin, and when should treatment be stopped or medical care sought?”
   Seven responses answer this, but coverage differs on contraindications and pregnancy-related considerations. Create an emergency-symptom versus contact-a-clinician format covering allergic, neurologic, skin, hepatic, and other serious reactions.

4. “I’m comparing ivermectin brands like Stromectol vs Heartgard—are these the same drug or different uses?”
   Current answers are relatively short—roughly 132–232 words—and repeatedly risk confusing shared active ingredient with interchangeable products. A human-versus-veterinary formulation explainer is a strong clarity and search opportunity.

5. “What’s the difference between ivermectin used orally in tablets and ivermectin used topically in creams?”
   Responses consistently identify route and intended use as the distinction, but several omit contraindication context. A comparison page covering formulation, route, approved uses, dosing principles, and why products must not be substituted would fill that gap.

2. Where competitors may be winning visibility

No named competitors appear in any of the 70 responses. Therefore, this dataset shows no identifiable competitor visibility gap on the brand questions. Visibility investment should focus on making authoritative ivermectin content more citable, rather than responding to a specific named competitor.

3. Topics worth resolving with authoritative content

• Adult scabies dosing: Resolve variation in repeat-dose timing, first-line permethrin context, crusted scabies, household/contact management, and contraindications.
• Strongyloidiasis in older adults: Answer “I have a 70-year-old with strongyloidiasis—how should ivermectin dosing be adjusted?” Cover age versus weight-based dosing, renal/hepatic considerations, interactions, severity, and follow-up.
• Contraindications: Define the difference between absolute avoidance and clinician-supervised caution, including allergy, age/weight, pregnancy/lactation, interactions, and Loa loa risk where relevant.

4. Prioritization — recurring vs. one-off

All 10 questions appear for the first time in the available history. No topic can yet be classified as recurring or growing. Prioritize the safety and dosing questions this week because each generated seven responses and includes inconsistency signals; monitor them next week before committing to a larger topic cluster.

5. Recommended content actions, ranked

1. Publish: “Can ivermectin be used for scabies, and what dose schedule is recommended for adults?” Resolve the two flagged inconsistency categories.
2. Publish: “Ivermectin contraindications: when should it be avoided?” Address the 17 total inconsistency flags and pregnancy/lactation ambiguity.
3. Publish: “Serious ivermectin adverse reactions: when to stop treatment and seek care?” Use symptom-based emergency guidance.
4. Create: “Stromectol vs Heartgard: same active ingredient, different products and uses,” targeting the shortest current answers.
5. Create: “Oral tablets vs topical ivermectin creams,” with a formulation and non-substitution comparison.